Purchase Order 12305B20P0077

This is a $11,590 firm-fixed-price purchase order awarded by the National Institutes of Health (NIH) to Peptide 2.0 Inc., a minority-owned small business, for the provision of custom peptides. The contract has a period of performance ending on March 25, 2015. Peptide 2.0 Inc., also doing business as Peptide 20 Inc., is a for-profit organization that specializes in custom peptide synthesis, production, and research, and has received several previous contract awards from the NIH and the U.S....

This $5,880.00 firm fixed price purchase order was awarded by the U.S. government to Biopeptide Co., Inc., a for-profit organization, manufacturer of goods, and Subchapter S Corporation, for the custom synthesis of 25 milligrams of a BCL11A-dimethyl peptide sequence with 95% purity. The contract, which has no set-aside designation, was awarded on March 19, 2009 with a final completion date of April 12, 2009. The place of performance is San Diego, California. No additional context about the...

The Department of Health and Human Services' National Institutes of Health's National Institute of Allergy and Infectious Diseases awarded a $11,453 purchase order to Genscript USA Inc. to provide custom peptide synthesis services in support of H1/HA programs. The firm fixed price contract runs from September 18, 2023 through December 29, 2023 and will be performed in Piscataway, New Jersey. Genscript will synthesize peptides to advance NIH's research on influenza viruses under the contract....

This is a firm fixed-price purchase order contract awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases to A & A Labs LLC, doing business as Synthetic Biomolecules. The $8,482.00 contract is for the custom synthesis of 15-mer peptides. The contract is set aside for small businesses and the awardee is a minority-owned, self-certified small disadvantaged business. The place of performance is San Diego,...

The Department of Health and Human Services' National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a firm-fixed-price purchase order to Protein Technologies Inc. (PTI), a manufacturer of peptide synthesis and bioanalytical technology equipment, to acquire a PurePep Chorus UV-IR peptide synthesizer for $107,107.16. The award provides for onsite installation and a startup kit. The purchase is made using simplified acquisition procedures and...

This is a firm fixed price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services (HHS), to Bio-Synthesis, Inc., a Hispanic American-owned small business. The contract is for custom peptide synthesis services, with a ceiling value of $3,259.00 and an ultimate completion date of February 25, 2015. The contract was awarded on February 18, 2015 and did not use a set-aside....

The Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases awarded a firm fixed-price purchase order to Peptide 2.0 Inc., doing business as Peptide 20 Inc., for custom peptide synthesis and production services. The award, which did not utilize a small business set-aside, has a potential value of $12,801.20 and a completion date of April 22, 2019. Peptide 2.0 Inc. is a minority-owned, for-profit organization that...

This federal contract award is for the CRUDE PEPTIDE SYNTHESIS, with a potential value of $22,593.00. The contract was awarded to A & A Labs LLC, doing business as Synthetic Biomolecules, a minority-owned, self-certified small disadvantaged business, and limited liability company. The contract is a purchase order with a firm fixed price, awarded by the Department of Health and Human Services, National Institutes of Health, National Institute of Allergy and Infectious Diseases. The place of...

The Department of Health and Human Services' National Institutes of Health (NIH) awarded a Firm Fixed Price purchase order contract to Peptide 2.0 Inc., doing business as Peptide 20 Inc., for the provision of custom peptides. The contract has a ceiling value of $7,310.00 and an ultimate completion date of September 20, 2014. Peptide 2.0 Inc. is a minority-owned, for-profit business that specializes in custom peptide synthesis and production services for federal agencies, particularly to...

This is a $81,460 firm fixed price purchase order awarded by the National Cancer Institute (NCI), which is part of the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services (HHS), to Pepscan Presto B.V., a foreign-owned for-profit company. The contract is for the acquisition, characterization, and optimization of constrained peptides targeting glypican, in support of the NCI's Molecular Imaging Program. The work will involve creating peptide libraries,...